Biopankkitutkimukset – 2026
Toward improved outcome in T-cell lymphomas by personalizing the diagnostics and treatmentOuti Kuittinen / University of Eastern Finland›
Anaplastic large cell lymphoma is a rare T-cell lymphoma subtype. Currently most patients are treated with autologous stem cell transplantation (ASCT), although its exact value in disease control is not known. Optimal treatment as well as the prognostic value of chromosomal abnormalities is unknown. Aim of the present study is to evaluate prognostic value of chromosomal translocations and mutational profile in order to enable the choice of optimal treatment to patients. We also aim to find new potential therapeutic targets in this disease.
